Introduction !

Mushroom bioactivity
For a long time, mushrooms have been playing an important role in several aspects of human activity. Edible mushrooms, for example, are used extensively in cooking and make up part of low-calorie diets. Mythology is extensively garnished by mushrooms and is typically associated with gnomes, fairies, and other fairytale personages.
The psychedelic and consciousness expansion properties of some species have pushed mushrooms to become part of some religions. Even toxic mushrooms have found a place of relevance, because of the uniqueness of their compounds that evolved naturally as a protection against consumption [1] . Wild and cultivated mushrooms contain a huge diversity of biomolecules with nutritional [2] and/or medicinal properties [3] [4] [5] . Due to these Abstract ! Despite the huge diversity of antibacterial compounds, bacterial resistance to first-choice antibiotics has been drastically increasing. Moreover, the association between multiresistant microorganisms and nosocomial infections highlight the problem, and the urgent need for solutions. Natural resources have been exploited in the last years and among them, mushrooms could be an alternative source of new antimicrobials. In this review, we present an overview of the antimicrobial properties of mushroom extracts and highlight some of the active compounds identified, including low-and high-molecular weight (LMW and HMW, respectively) compounds. LMW compounds are mainly secondary metabolites, such as sesquiterpenes and other terpenes, steroids, anthraquinones, benzoic acid derivatives, and quinolines, but also primary metabolites such as oxalic acid. HMW compounds are mainly peptides and proteins. Data available from the literature indicate a higher antimicrobial activity of mushroom extracts against gram-positive bacteria. Among all the mushrooms, Lentinus edodes is the most studied species and seems to have a broad antimicrobial action against both grampostive and gram-negative bacteria. Plectasin peptide, obtained from Pseudoplectania nigrella, is the isolated compound with the highest antimi-crobial activity against gram-positive bacteria, while 2-aminoquinoline, isolated from Leucopaxillus albissimus, presents the highest antimicrobial activity against gram-negative bacteria.
Abbreviations ! CSAP:
Cordyceps sinensis antibacterial protein CFU:
colony forming unities ERSP:
erythromycin-resistant Streptococcus pyogenes HMW:
high-molecular weight compounds IC 50 A Review on Antimicrobial Activity of Mushroom (Basidiomycetes) Extracts and Isolated Compounds properties, they have been recognized as functional foods, and as a source for the development of medicines and nutraceuticals. Fruiting bodies, mycelia, and spores accumulate a variety of bioactive metabolites with immunomodulatory, cardiovascular, liver protective, antifibrotic, anti-inflammatory, antidiabetic, antiviral, antioxidant, antitumor, and antimicrobial properties [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] . The frequent use of mushrooms is based on three main assumptions: first, they are used as part of a regular diet for their nutritional value (since they are rich in water, minerals, proteins, fibers, and carbohydrates, and are low-caloric foods due to a low content in fat [2] ); secondly, fruiting bodies are also appreciated for their delicacy (they are palatability enhancers of flavor and aroma when associated to other foods); and thirdly, mushrooms are widely used for medicinal purposes. Their pharmacological action and therapeutic interest in promoting human health have been known for thousands of years [5, 15, 16] .
In particular, mushrooms could be a source of natural antibiotics, which can be LMW and HMW, respectively, compounds. LMW compounds are mainly secondary metabolites such as sesquiterpenes and other terpenes, steroids, anthraquinone and benzoic acid derivatives, and quinolines, but also primary metabolites such as oxalic acid (l " Fig. 1 ). HMW compounds mainly include peptides and proteins. It is estimated that there are about 140 000 species of mushrooms on earth, and of these only 22 000 are known and only a small percentage (5 %) has been investigated. Therefore, there is Fig. 1 Chemical structure of the low-molecular weight (LMW) compounds with antimicrobial potential found in mushrooms.
much to explore about mushroom properties and potential applications [4] .
Bacteria and drug discovery
The development of antibiotics has been one of the most important scientific achievements of the last seventy years. These compounds act in several ways, by interfering in metabolic processes or in the organism structures [17] . The mechanism of action is mostly related with interferences in the synthesis of the cell wall, modification of plasmatic membrane permeability, interferences in chromosome replication, or in protein synthesis [18] . The cell wall is responsible for the shape and rigidity of bacterial cells, acting as an osmotic barrier [19] . The peptidoglycan content in the cell wall varies between 10 % and 60% for gram-negative and gram-positive bacteria, respectively [20, 21] . Antiparietal antibiotics act in one of the phases of peptidoglycan synthesis, being classified according to that phase. Phosphomycin, D-cycloserine, glycopeptides (bacitracin, vancomycin, teicoplanin), and beta-lactams (penicillins, cephalosporins, carbapenemics, monobactamics) are some examples of this group [22] . Otherwise, other antibiotics such as ascolistin and daptomycin act at the cell membrane level. Aminoglycosides and tetracyclines, macrolides, oxazolidines, quinupristin and dalfopristin, clindamycin, and chloramphenicol inhibit protein synthesis by interfering with 30 s or 50 s ribosomal subunits. Quinolones, rifampicin, and metronidazol inhibit nucleic acid synthesis. Sulfonamides and trimetoprim are antimetabolic antibiotics that inhibit the metabolic chain of PABA, essential to cell growth [23] . Despite the huge diversity of antibacterial compounds, bacterial resistance to first-choice antibiotics has been drastically increasing. Some examples are microorganisms such as Klebsiella spp. and Escherichia coli, which produce broad-spectrum beta-lactamase or present resistance to third-generation cephalosporins.
Other examples include MRSA, Enterococcus spp., which is resistant to vancomycin [24, 25] , Acinetobacter spp. with an increasing resistance to carbapenems and colistin [26] , and Pseudomonas spp., which is resistant to aminoglycosides, carbapenemics. and/ or cephalosporins [24] . Diseases that were easily healed are nowadays becoming a serious problem due to emergent antibiotic resistance [27, 28] . The association between multiresistant microorganisms and hospital infections certainly highlights this problem and the urgent need for solutions [29] . In 2010, the World Health Organization advised all countries to implement control procedures for the propagation of drug multiresistant bacteria, highlighting the risks associated to the absence of alternative therapies against those microorganisms [30] . Therefore, the research of new antimicrobial substances effective against pathogenic microorganisms resistant to current drugs is crucial. New groups of organisms, such as marine, have been increasingly explored in the last years, and among them, mushrooms could be an alternative source for new antimicrobials. In this review, we provide an overview about the antimicrobial properties of mushroom extracts and highlight selected compounds. The databases searched were Medline (1980 to March 2012) and Web of Science (2001 to March 2012) including scientific articles and conference proceedings. Search terms were: "mushrooms", "antimicrobial activity", and "antimicrobials". An exhaustive literature search was performed, but only mushroom extracts and isolated compounds with positive results were included.
Antimicrobial Activity Against Gram-Positive Bacteria !
Methodologies
Different methodologies have been used to assess antimicrobial activity of mushroom extracts and compounds, including the microdilution method, the disk diffusion method, the agar streak dilution method based on radial diffusion, and a method with the incorporation of the extract in the culture medium and further determination of colonies. Therefore, the results for antimicrobial activity are expressed in different unities (l " Tables 1 and 2). The microdilution method comprises microdilutions of the extract in liquid medium using microplates to determine MIC or IC 50 values. In the disk difusion method, the extract is incorporated in disks at different concentrations, and the halo of growth inhibition is determined and represented by IZD (internal zone diameter) values. The agar streak dilution method based on radial diffusion is most widely used in extracts and implies the extract application in circular holes made in solid medium. The result might be expressed in IZD or MIC values. Regarding the fourth method, the extract is incorporated in the culture medium and then CFU are determined.
Mushroom extracts with antimicrobial activity
Numerous mushroom extracts have been reported as having antimicrobial activity against gram-positive bacteria (l " Table 1 ). Agaricus bisporus, the most cultivated mushroom in the world, should be highlighted. Its methanolic extract revealed MIC = 5 µg/mL against Bacillus subtilis, even lower than the standard ampicillin (MIC = 12.5 µg/mL) [31] , and also showed activity against Bacillus cereus, Micrococcus luteus, Micrococcus flavus, Staphylococcus aureus, and Staphylococcus epidermidis [15, 32, 33] . Other Agaricus species have also demonstrated antimicrobial activity. Agaricus bitorquis and Agaricus essettei methanolic extracts showed an inhibitory effect upon all the tested gram-positive bacteria [15] . Agaricus silvicola methanolic extract also revealed antimicrobial properties against Bacillus cereus (MIC = 5 µg/mL), Bacillus subtilis (MIC = 50 µg/mL), and against Staphylococcus aureus (MIC = 5 µg/mL), lower than the standard ampicillin (MIC = 6.25 µg/mL) [31] . The mycelium of Agaricus cf. nigrecentulus and Tyromyces duracinus (ethyl acetate extracts) showed activity only against Staphylococcus saprophyticus [34] .
The ethanolic extracts of Armillaria mellea mycelium showed an antibacterial effect against Sarcina lutea; however, no activity was observed upon other gram-positive bacteria [35] . However, the ethanolic extract of their fruiting bodies showed broad-spectrum antimicrobial activity [36] . The most studied mushroom of the genus Boletus is Boletus edulis. Its methanolic mushroom showed lower antimicrobial activity than other species studied by Ozen et al. [32] . Nevertheless, Barros et al. [31] reported an MIC = 5 µg/mL against Staphylococcus aureus, lower than ampicillin (MIC = 6.25 µg/mL). Cantharellus cibarius methanolic extract demonstrated good activity against Bacillus subtilis and Staphylococcus aureus [31, 32, 37] . This mushroom also showed activity against Bacillus cereus in some studies [32, 37] , but it was not so effective in another report [31] , which could be related to the different methodologies used to evaluate antimicrobial activity. Clitocybe alexandri methanolic extract presented significant activity against Bacillus subtilis and Micrococcus luteus [38] . Kalyoncu et al. [36] tested antimicrobial activity of chloroform and ethanolic extracts from Clitocybe geotropa, the latter showing asignificant capacity against Bacillus cereus. 
Streptococcus salivarius
Lentinus edodes MIC = 0.1-10 mg/mL [54] The genus Cortinarius is one of the most diverse genera of mushrooms. Ethyl acetate extracts of C. ardesiacus, C. archeri, C. atrosanguineus, C. austrovenetus, C. austroviolaceus, C. coelopus, C.
[Dermocybe canaria], C. clelandii, C. [D. kula], C. memoria-annae, C. persplendidus, C. sinapicolor, C. vinosipes, and 47 other collection samples not identified to the species level, exhibited IC 50 values of ≤ 0.09 mg/mL against Staphylococcus aureus [10] . However, in a study reported by Ozen et al. [32] , Cortinarius sp. methanolic extracts showed lower activity against Staphylococcus aureus. This demonstrates the effect of solvent extraction in the type and concentration of compounds present in the final extract and, consequently, the spectrum of antimicrobial activity. Ganoderma lucidum is one of the most famous traditional medicinal mushrooms. Various extracts have been found to be equally effective when compared to gentamycin sulphate, the acetone extract being the most effective. This mushroom had moderate inhibition against Bacillus subtilis and Staphylococcus aureus for any extract [39] , but in the study reported by Sheena et al. [40] , its methanolic extract showed poor antimicrobial activity. Other authors described the capacity of the aqueous extract to inhibit 15 types of gram-positive and gram-negative bacteria, with the highest inhibition exhibited against Micrococcus luteus [41] . Ethyl acetate extracts of Phellinus sp., Gloeoporus thelephoroides, and Hexagonia hydnoides inhibited Bacillus cereus growth, while the same extract of Nothopanus hygrophanus mycelium presented inhibitory activity against Listeria monocytogenes and Staphylococcus aureus. Irpex lacteus mycelium extract was the most effective, presenting a broad spectrum of activity [34] . The antimicrobial activity of Pycnoporus sanguineus has been known since 1946, when Bose isolated poliporin, a compound active against gram-positive and gram-negative bacteria and without toxicity in experimental animals. Rosa et al. reported inhibition against Listeria monocytogenes and Staphylococcus aureus [34] . Smânia et al. [42, 43] showed that this mushroom produces cinnabarine, an orange pigment active against Bacillus cereus, Staphylococcus aureus, Leuconostoc mesenteroides, Lactobacillus plantarum, and several Streptococcus spp. Cinnabarine was more active against gram-positive than gram-negative bacteria [34] . The chloroform extract of Hygrophorus agathosmus and dichloromethane of Suillus collitinus were active against all the tested gram-positive bacteria. The highest antibacterial activity was seen in the extract of H. agathosmus against Staphylococcus epidermidis and Bacillus subtilis, with MIC values 7.81 µg/mL lower than the reference antibiotic streptomycin (MIC = 15.62 µg/mL). MIC values (15.62 µg/mL) against Staphylococcus aureus were equal to the ones of streptomycin. Suillus collitinus showed MIC values much higher than the standard [44] . One nonedible mushroom, Hypholoma fasciculare (methanolic extract), presented high antimicrobial activity against gram-positive bacteria, namely Bacillus cereus, Bacillus subtilis, and Staphylococcus aureus [37] . All the tested gram-positive bacteria were susceptible to methanolic extracts of Lactarius species and Tricholoma portentosum [32, 45, 46] . Among Lactarius species (L. piperatus, L. camphorates, L. volemus, L. delicious), L. camphoratus methanolic extract was the one with greater antimicrobial activity [32] . Methanolic extracts of Ramaria botrytis and the ethanolic extract of Ramaria flava inhibited the growth of gram-positive bacteria better than gram-negative bacteria [47] . The antimicrobial effect of the ethanolic extract of Laetiporus sulphureus was tested by Turkoglu et al. [48] and strongly inhibited the growth of the gram-positive [50, 51] . Furthermore, Streptococcus pyogenes was very sensitive to the Lentinus edodes chloroform extract [52] . The ability of L. edodes extracts to improve oral health has also been extensively researched, since it showed a strong bactericidal effect upon Streptococcus mutans, which is strongly implicated in dental caries and tooth decay [53, 54] . The mycelium of Leucopaxillus giganteus (methanolic extract) presented antimicrobial capacity, inhibiting only gram-positive bacteria and, in decreasing order, Staphylococcus aureus > Bacillus cereus > Bacillus subtilis [55] . The authors stated that the most promising nitrogen source to produce mushrooms with an increased content in bioactive compounds that inhibit gram-positive bacteria growth was (NH 4 ) 2 HPO 4 .
The methanolic extracts of Phellinus rimosus and Navesporus floccosa showed moderate inhibition of Bacillus subtilis and Staphylococcus aureus [40] . Pleurotus ostreatus and Meripilus giganteus showed broad-spectrum antimicrobial activity. microorganism was also inhibited by Phellinus linteus [51] and Pleurotus ostreatus [50] . It is important to develop new studies with different mushroom species and, moreover, with these microorganisms that are so problematic to human health.
Antimicrobial compounds from mushrooms
Most studies on mushrooms with antibacterial activity describe the action of its extracts without identifying the compounds responsible for this activity. However, some compounds have been described as active against gram-positive bacteria (l " Table 2 ). Five of these compounds are terpenes. Confluentin (1a), grifolin (1b), and neogrifolin (1c) from Albatrellus fletti showed activity against Bacillus cereus and Enterococcus faecalis. The best result was for Enterococcus faecalis (MIC 0.5 to 1.0 mg/mL) [56] . Ganomycin A and B (5 a, b), isolated from Ganoderma pfeifferi, showed activity against Bacillus subtilis, Micrococcus flavus, and Staphylococcus aureus (15-25 mm zones of inhibition at a concentration of 250 µg/mL [57] . A steroid, 3,11-dioxolanosta-8,24(Z)-diene-26-oic acid (2), was isolated from the Jahnoporus hirtus mushroom and revealed activity against Bacillus cereus and Enterococcus faecalis [56] . Four sesquiterpenes with antimicrobial activity were described. The enokipodins A, B, C, and D (4a-d), isolated from the mycelium of Flammulina velutipes, with activity against Bacillus subtilis, but only enokipodins A and C showed activity against Staphylococcus aureus [58] . Oxalic acid (3), an organic acid, isolated from the mycelium of Lentinus edodes, showed activity against Bacillus cereus, Staphylococcus aureus, and Streptococcus faecalis [59] . Coloratin A (10), a benzoic acid derivative isolated from Xylaria intracolarata, inhibited Staphylococcus aureus [60] . Eight compounds anthraquinone derivatives were also reported due to their antibacterial activities. 6-Methylxanthopurpurin-3-O-methyl ether (7), (1S,3S)-austrocortilutein (8a), (1S,3R)-austrocortilutein (8b), (1S,3S)-austrocortirubin (8c), and torosachrysone (8 d), isolated from the mushroom Cortinarius basirubencens, and physcion (9a), erythroglaucin (9b), and emodin (9c), isolated from other species of Cortinarius, were all effective against Staphylococcus aureus [10] . In addition to the LMW compounds already mentioned, several antimicrobial compounds with HMW have also been described, in particular, proteins and peptides. CSAP (Cordyceps sinensis antibacterial protein-N-terminal sequence ALATQHGAP), isolated from Cordyceps sinensis, showed strong activity against Staphylococcus aureus and poor activity against Bacillus subtilis. However, the antibacterial action of this protein was bacteriostatic [61] . 
Methodologies
The same methodologies already described for gram-positive bacteria are also used in the evaluation of mushroom extracts or compounds antimicrobial activity against gram-negative bacteria. The results are presented in l " Tables 3 and 4 .
Mushroom extracts with antimicrobial activity
The antimicrobial activity against gram-negative bacteria shown by different mushroom extracts is not so extensive and is shown in l " Table 3 .
The results for Agaricus bisporus are contradictory. Barros et al. [31] and Öztürk et al. [15] found no activity against gram-negative bacteria, while Ozen et al. [32] and Tambeker et al. [33] reported positive activity mainly against Escherichia coli, but also against Pseudomonas aeruginosa, Enterobacter aerogenes, Klebsiella pneumoniae, Proteus vulgaris, Salmonella typhi, and Salmonella typhimurium. However, these divergences may be due to different methods and concentrations used. Agaricus bitorquis methanolic extract had some effects against three of the gramnegative bacteria, namely Yersinia enterocolitica, Klebsiella pneumoniae, and Proteus vulgaris [15] . Agaricus essettei, Agaricus silvicola, Agaricus silvaticus, and Agaricus cf. nigrecentulus did not show any antibacterial activity against gram-negative bacteria [15, 31, 34] . Ethanolic extracts of Armillaria mellea fruiting bodies revealed better antimicrobial activity than chloroform extracts and mycelium extract upon gram-negative bacteria [35, 36] . According to Barros et al. [31, 37] , Cantharellus cibarius showed no activity against gram-negative bacteria, as opposed to Ozen et al. [32] , who reported there was activity against Escherichia coli and Pseudomonas aeruginosa. Enterobacter aerogenes and Escherichia coli were inhibited by the methanolic extract of Clitocybe alexandri [38] . Clitocybe geotropa chloroform and ethanolic extracts inhibited the growth of all gram-negative bacteria tested, with Proteus vulgaris being the most sensitive [36] . Beatttie et al. [10] reported anti-Pseudomonas aeruginosa activity of the genus Cortinarius and its subgenus, Dermocybe (methanolic extracts). Four species were tested, namely C. abnormis, C. austroalbidus, C. [D. kula], C. persplendidus, and eleven Cortinarius collection samples not identified to the species level, obtaining IC 50 values ≤ 0.09 mg/mL against P. aeruginosa. The acetone extract from Ganoderma lucidum showed strong antibacterial activity, mainly against Klebsiella pneumonia [39] .
Further studies indicate that the antimicrobial combination of G. lucidum extracts with chemotherapeutic agents (ampicillin, cefazolin, oxytetracycline, and chloramphenicol) resulted in syner- [66] . The Hydnum repandum methanolic extract was mainly active against Pseudomonas aeruginosa. Escherichia coli was found to be the most sensitive bacteria to methanolic extracts of Lactarius species [32] . However, no activity of Lactarius delicious against E. coli was observed [45, 46] . The Laetiporus sulphureus ethanolic extract had a lower antibacterial spectrum against gram-negative bacteria, having no activity against Klebsiella pneumonia [48] . On three occasions, namely with the Pseudomonas sp., Lentinus edodes aqueous extract was significantly more active than ciprofloxacin (positive control), whereby it gave markedly greater zones of inhibition. This result is of important clinical significance, as P. aeruginosa is emerging as a major etiological of the nosocomial infection [50] . L. edodes mycelium had no effect on Escherichia coli, Pseudomonas fluorescens, Klebsiella pneumoniae, and Camphylobacter jejuni [52] . Extracts from Lentinus edodes showed a strong bactericidal effect against Prevotella intermedia, which is associated with gingivitis. This mushroom was capable of significantly reducing dental plaque deposition [53, 54, 67, 68] .
The Lepista nuda methanolic extract was effective against Escherichia coli and Pseudomonas aeruginosa [49] . Tambeker et al. [33] reported the antimicrobial ability of several extracts of Pleurotus sajor-caju. Escherichia coli, Enterococcus aerogenes, Pseudomonas aeruginosa, and Klebsiella pneumoniae were most sensitive to ethanolic, methanolic, and xylene extracts.
Overall, among the tested gram-negative bacteria, Escherichia coli and Klebsiella pneumoniae are the most susceptible to mush-roomsʼ inhibitory effect. Agaricus bisporus [32, 33] , Lentinus edodes [50, 54] , Ganoderma lucidum [39, 40] , and Lepista nuda [49] seem to have higher antimicrobial activity against those microorganisms. Pseudomonas aeruginosa was inhibited by Clitocybe alexandri [38] , Boletus edulis, Cantharellus cibarius [32] , Ganoderma lucidum [39] , and Cortinarius sp. [10] extracts. Studies with Enterobacter aerogenes and Serratia marcescens are scarce, and due to the importance in the area of multiresistance, they should be carrried out to assess sensibility to extracts from mushroom species.
Antimicrobial compounds from mushrooms
Some of the compounds previously discussed have also been described for their action against gram-negative bacteria (l " Table  4 ). Terpenes 5a and 5b, isolated from Ganoderma pfeifferi, showed moderate activity against Escherichia coli, Proteus mirabilis, and Serratia marcescens [57] . The organic acid 3, isolated from the mycelium of Lentinus edodes, showed activity against Klebsiella pneumoniae, Proteus vulgaris, Pseudomonas aeruginosa, and Pseudomonas fluorescens [59] . The benzoic acid derivative 10, isolated from Xylaria intracolarata, showed activity against Escherichia coli, Klebsiella pneumonia, Pseudomonas aeruginosa, and Salmonella enteritidis. For this compound, the highest inhibition (22 mm) was found in Klebsiella pneumonia, which is higher than the control (gentamicin, 14 mm) [60] . Compounds 7, 8a-d (Cortinarius basirubescens), and 9a-c (Cortinarius spp.) were effective against Pseudomonas aeruginosa [10] . The quinoline 6, isolated from Leucopaxillus albissimus, showed activity against Achromobacter xyloxidans, Acinetobacter baumannii, Burkholderia cenocepacia, Burkholderia cepacia, Burkholderia multivorans, Cytophaga johnsonae, and Pseudomonas aeruginosa. Among the thirteen microorganisms tested, Cytophaga johnsonae was the most strongly inhibited (16 mm) [69] . Some proteins have also been reported against gram-negative bacteria. The protein CSAP, isolated from Cordyceps sinensis and already mentioned above, showed activity against Escherichia coli, Proteus vulgaris, and Salmonella typhi [61] , while the protein (N-terminal sequence SVQATVNGDKML) isolated from Clitocybe sinopica was active against Agrobacterium rhizogenes, Agrobacterium tumefaciens, Agrobacterium vitis, Xanthomonas malvacearum, and Xanthomonas oryzae [70] . Ribonuclease (Pleurotus sajor-caju) showed activity against Pseudomonas aeruginosa and Pseudomonas fluorescens, acting at the RNA level [62] . Fraction B (Pycnoporus sanguineus) showed activity against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Salmonella typhi [42] . Unfortunatly, the mechanism of action of each one of the isolated compounds is not completly clear and described in the available reports.
Concluding Remarks
!
The present review focuses on the antimicrobial effects of mushrooms from all over the world, and their isolated compounds. It will certainly be useful for future scientific studies. Both edible and nonedible mushrooms showed antimicrobial activity against pathogenic microorganisms, including bacteria associated with nosocomial infections (Pseudomonas aeruginosa, Pseudomonas maltophila, Listeria monocytogenes, Staphylococcus aureus, Klebsiella pneumoniae, Morganella morganii, Proteus mirabilis, Serratia marcescens) and multiresistance (MRSA, MRSE, VREF, PRSP, ERSP). Data available from the literature indicates that mushroom extracts and isolated compounds exhibit higher antimicrobial activity against gram-positive than gram-negative bacteria. Among all the mushrooms, Lentinus edodes is the best-studied species and seems to possess broad antimicrobial action against both gram-positive and gram-negative bacteria. Species from the genera Boletus, Ganoderma, and Lepista appear promising for future studies, if one considers the positive activity and limited number of publications. Considering the low number of studies with individual compounds, Plectasin peptide, isolated from Pseudoplectania nigrella, revealed the highest antimicrobial activity against gram-positive bacteria. The comparison of the results reported by different authors is difficult, due to the diverse methodologies used to evaluate antimi-crobial activity of mushroom extracts or isolated compounds. Therefore, the standardization of methods and establishment of cut-off values is urgent. The knowledge about the mechanisms of action of different compounds might lead to the discovery of new active principles for antimicrobial activity. Furthermore, the application of cytotoxicity assays is also important to evaluate the effects on humans in the range of the in vitro tested concentrations.
The research on mushrooms is extensive and hundreds of species have demonstrated a broad spectrum of pharmacological activities, including antimicrobial activity. Although there are a number of studies available in the literature, they are almost entirely focused on the screening of antibacterial properties of mushroom extracts. In fact, there is a gap in the identification of the individual compounds responsible for those properties, and only a few low-molecular weight compounds and some peptides and proteins have been described. After elucidation of their mechanism of action, these mushroom metabolites or other related compounds could be used to develop nutraceuticals or drugs effective against pathogenic microorganisms resistant to conventional treatments.
